president
Dr. Ladislav Csémy
Researcher in epidemiology, addictions and social psychiatry at the National Institute of Mental Health (NIMH). Dr. Csémy graduated from Psychology at the Faculty of Arts of the Charles University in Prague. For a long time, he has been working at NIHM as the Head of the Centre for Epidemiological and Clinical Research on Addictions.
His professional interests include psychological and social-medical aspects of addictive behaviour, psychiatric epidemiology and health psychology.
Dr. Csémy contributed to more than ten monographs and has worked on a number of research studies and community-based prevention projects. In the past, he received the professor Vladimir Vondracek’s National Psychiatric Award for his research work.
SCIENTIFIC BOARD
Assoc. Prof. Dr. Viktor Mravčík, Ph.D.
Assoc. Prof. Dr. Viktor Mravčík, Ph.D., iis Head of the Research Department at the Institute for Rational Addiction Policy and a deputy member of the Management Board of the European Union Drugs Agency (EUDA). He serves as an expert on numerous international projects in the fields of drug policy and drug‑situation monitoring. He has extensive experience training colleagues from countries that are either preparing to monitor the drug situation in line with EUDA standards or are deepening their competence in this area.
Doc. Mravcik teaches methodology and drug epidemiology at the Department of Addictology of the First Faculty of Medicine at the Charles University in Prague. He is also a research associate of the National Institute of Mental Health (NIMN) and a member of the board of the doctoral program in addictology at the First Faculty of Medicine of the Charles University.
Moreover, Doc. Mravcik is a member of the Committee on Addictive Diseases of the Czech Medical Association of J.E. Purkyne , member of the editorial board of the Journal on Addictology and the winner of the award of the Journal of Czech Physicians for the best work in 2010. Last but not least, he received the Josef Skala’s award for his publication activities in the field of addictology in 2017.
Prof. Dr. Eva Králíková, CSc.
Prof. MUDr. Eva Kralikova, CSc. has been involved in epidemiology, prevention and treatment of tobacco dependence for nearly 30 years. Currently, she is a teacher at the Institute of Hygiene and Epidemiology of the First Faculty of Medicine of the Charles University in Prague and at the General University Hospital in Prague.
Prof. Kralikova leads the Centre for Tobacco Addicted at the Third Internal Clinic of the First Faculty of Medicine of the Charles University. She is also chairwoman of the Society for the Treatment of Tobacco Addiction (see: www.slzt.cz).
Univ. Doz. Dr., Ernest Groman
Univ. Doz. Dr. Ernest Groman is a Scientific Director of the Nicotine Institute in Vienna. In the past, he worked for the Public Health Center (Institute of Social Medicine of the University of Vienna). Since 2002, he has been involved in the development and implementation of smoking cessation programs in Lower Austria. His scientific activities and intervention projects have covered more than 76 cities in Lower Austria with a combined population of around 1.6 million people.
Doc. Groman also worked as a Scientific Advisor to the Austrian government, the Austrian Pharmaceutical Chamber, and the Austrian smoking cessation hotline. He represented Austria as a delegate to the WHO in the context of the negotiations on the Global Framework Convention on Tobacco Control.
Ernest Groman graduated from the Medical Faculty of the University of Vienna. In his habilitation procedure, he specialized in tobacco and public health issues. In this area, he wrote more than 100 professional articles and a co-authored several books.
RNDr. Ladislav Kážmér, Ph.D.
RNDr. Ladislav Kážmér, Ph.D., completed his postgraduate studies in the field of social geography at the Faculty of Science, Charles University in Prague. He completed his master’s studies at Comenius University in Bratislava, Slovakia. In his work, he focuses on the issues of social and socio-spatial determinants of population health.
Dr. Fabian Pitter Steinmetz
Fabian Pitter Steinmetz is certified toxicologist working for the international consultancy Delphic HSE. After some experience in the pharmaceutical industry, he completed his PhD in predictive toxicology at Liverpool John Moores University in 2016. Scientifically, he is interested in quantitative structure-activity relationships, novel psychoactive substances, but also in regulatory approaches focussing on harm reduction. He is active in several national and international organisations that advocate for drug policy reform.
Jakub Popík, E.MA.
Jakub Popík is a human rights officer, PhD student at the Institute of Sociology of the Slovak Academy of Sciences, drug policy advisor and director of the Harm Reduction Institute. In his work, he seeks to improve communication and cooperation between entities tasked with the protection of human rights, whether from the media, non-profit, state, or private sector, in order to eliminate all forms of prejudice from society.
Krzysztof Łanda, M.D.
Krzysztof is President of the Ukrainian Evidence‑Based Healthcare Society, a partner at HTA Formedis and CEO of MedInvest Scanner; in 2023–24 he advised Ukraine’s Minister of Health. He was previously Poland’s Deputy Minister of Health (2015–17), led HTA Audit, the Watch Health Care foundation and a regional HTA society, worked at Dentons, and directed HTA capacity‑building projects in Ukraine, Kazakhstan and Serbia.
REGULATORY BOARD
Tomáš Sadílek
Tomáš Sadílek has an extensive experience working for the Office of the Government of the Czech Republic in the field of legal and illegal drugs. He represented the Czech Republic in drug-related meetings in the United Nations institutions in Vienna and New York and in meetings in the EU area, Eastern Partnership countries area, and the US.
Mgr. Mikuláš Peksa, Ph.D.
Mgr. Mikuláš Peksa, Ph.D., is CEO of Cybermindnet. Studied biophysics at Charles University in Prague. Between 2017 and 2019 active as Member of Czech Parliament, 2019 to 2024 as Member of European Parliament.